Pharming Group N.V. (PHAR) vs Verastem (VSTM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Pharming Group N.V. (PHAR) has outperformed Verastem (VSTM) over the past year, losing 29.0% versus a loss of 36.7%. Over five years, PHAR leads with a +39.0% price change compared with -80.3% for VSTM. Pharming Group N.V. is the larger company by market cap ($816.8 million vs $797.7 million), about 1.0 times the size, while Verastem is growing revenue faster (+209.1% vs +26.6%).
Pharming Group N.V. converts more of its revenue into profit, with a net margin of 0.8% versus -677.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PHAR | VSTM |
|---|---|---|
| Share price | $11.54 | $6.33 |
| Market cap | $816.78M | $797.67M |
| 1-day change | -5.10% | -7.73% |
| YTD return | -34.69% | -18.01% |
| 1-year return | -29.03% | -36.70% |
| 5-year return | +39.04% | -80.32% |
| P/E ratio (TTM) | 36.06 | — |
| Forward P/E | 64.11 | — |
| EPS (TTM) | $0.32 | $-1.84 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $376.13M | $30.91M |
| Revenue growth (YoY) | +26.56% | +209.14% |
| Net income (latest FY) | $2.85M | $-209.47M |
| Gross margin | 87.90% | — |
| Operating margin | 6.87% | -550.33% |
| Net margin | 0.76% | -677.59% |
| 52-week high | $21.34 | $10.82 |
| 52-week low | $9.11 | $3.43 |
| Distance from 52-week high | -45.92% | -41.50% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +209.36% | +172.04% |
| Average volume | 21.33K | 3.53M |
| Shares outstanding | 70.78M | 126.01M |
| Employees | 407 | 102 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Pharming Group N.V. is more profitable, keeping 0.8 cents of every revenue dollar as net income versus -677.6 cents for Verastem.
- Verastem grew revenue faster in its latest fiscal year (+209.14% vs +26.56%).
About Pharming Group N.V.
PHAR stock →Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kd inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
Health Care · Biotechnology: Pharmaceutical Preparations · 407 employees
About Verastem
VSTM stock →Verastem, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing drugs for the treatment of cancer in the United States. Its product candidates are Avutometinib, which is an orally administered, small molecule dual RAF/MEK inhibitor developed to block MEK kinase activity and the compensatory reactivation of MEK by upstream RAF, thereby targeting the RAS/MAPK signaling pathway that is commonly activated in various cancers; and Defactinib, an oral small molecule inhibitor of FAK and proline-rich tyrosine kinase for various solid tumors.
Health Care · Biotechnology: Pharmaceutical Preparations · 102 employees
PHAR vs VSTM FAQ
Which is bigger, Pharming Group N.V. or Verastem?
Pharming Group N.V. (PHAR) is larger, with a market capitalization of $816.78M compared with $797.67M for Verastem (VSTM).
Which stock has performed better over the past year, PHAR or VSTM?
PHAR returned -29.03% over the past 12 months, compared with -36.70% for VSTM (price return, excluding dividends). Past performance does not predict future results.
Are Pharming Group N.V. and Verastem in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.